Motus GI Holdings Inc
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in Nov… Read more
Market Cap & Net Worth: Motus GI Holdings Inc (MOTS)
Motus GI Holdings Inc (OTCQB:MOTS) has a market capitalization of $638.89 ($638.89) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #48760 globally and #14964 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Motus GI Holdings Inc's stock price $0.00 by its total outstanding shares 6388876 (6.39 Million).
Motus GI Holdings Inc Market Cap History: 2018 to 2025
Motus GI Holdings Inc's market capitalization history from 2018 to 2025. Data shows change from $5.96 Billion to $638.89 (-89.95% CAGR).
Motus GI Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Motus GI Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
25.54x
Motus GI Holdings Inc's market cap is 25.54 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $5.96 Billion | $36.00K | -$22.26 Million | 165578.37x | N/A |
| 2019 | $4.39 Billion | $107.00K | -$22.59 Million | 41020.17x | N/A |
| 2020 | $1.82 Billion | $98.00K | -$19.60 Million | 18540.78x | N/A |
| 2021 | $895.08 Million | $391.00K | -$18.91 Million | 2289.21x | N/A |
| 2022 | $80.50 Million | $592.00K | -$18.09 Million | 135.98x | N/A |
| 2023 | $8.15 Million | $319.00K | -$12.87 Million | 25.54x | N/A |
Competitor Companies of MOTS by Market Capitalization
Companies near Motus GI Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Motus GI Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Motus GI Holdings Inc Historical Marketcap From 2018 to 2025
Between 2018 and today, Motus GI Holdings Inc's market cap moved from $5.96 Billion to $ 638.89, with a yearly change of -89.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $638.89 | 0.00% |
| 2024 | $638.89 | -99.99% |
| 2023 | $8.15 Million | -89.88% |
| 2022 | $80.50 Million | -91.01% |
| 2021 | $895.08 Million | -50.74% |
| 2020 | $1.82 Billion | -58.60% |
| 2019 | $4.39 Billion | -26.37% |
| 2018 | $5.96 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Motus GI Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $638.89 USD |
| MoneyControl | $638.89 USD |
| MarketWatch | $638.89 USD |
| marketcap.company | $638.89 USD |
| Reuters | $638.89 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.